Gary Owens, MD, and David Rosmarin, MD, highlight key takeaways in vitiligo treatment as produced by the TRuE-V studies.
EP. 1: TRuE-V Studies Overview and Unmet Needs in Vitiligo
Drs. Owens and Rosmarin discuss an overview of the TRuE-V studies and unmet needs in vitiligo.
EP. 2: Safety and Efficacy Data Results at 24-Week Mark of TRuE-V Studies
The key safety and efficacy data of the TRuE-V studies are discussed.
EP. 3: TRuE-V Long-Term Extension Study Design
The study design for the TRuE-V long-term extension study is discussed.
EP. 4: Key Results from the TRuE-V Long-term Extension Study
Dr. Rosmarin discusses the efficacy data from the TRuE-V long-term extension study.
EP. 5: Notable Adverse Events from TRuE-V Studies
Key adverse events from the TRuE-V studies are highlighted.
EP. 6: Evaluating TRuE-V Study Limitations
The limitations from the TRuE-V studies are analyzed.
EP. 7: Payer Considerations Surrounding TRuE-V Studies
Drs. Owens and Rosmarin discuss payer and provider perspectives from the TRuE-V studies.
2 Commerce Drive Cranbury, NJ 08512